Metabolism and transfer of the mycotoxin zearalenone in human intestinal Caco-2 cells

Food and Chemical Toxicology

Volumn 46, Issue 10, 2008, Pages 3279-3286

  Videmann, Bernadette ^a   Mazallon, Michelle ^a   Tep, Jonathan ^a   Lecoeur, Sylvaine ^a  

^a VETAGRO SUP   (France)

Author keywords

Intestinal cells; Metabolism; Mycotoxin; Transfer; Zearalenone

Indexed keywords

INDOMETACIN; PREGNENOLONE; ZEARALENONE;

ARTICLE; CELL DAMAGE; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; HUMAN; HUMAN CELL; INTESTINE CELL; INTRACELLULAR SPACE;

3-HYDROXYSTEROID DEHYDROGENASES; BIOLOGICAL TRANSPORT; CACO-2 CELLS; ESTROGENS, NON-STEROIDAL; HUMANS; INTESTINAL NEOPLASMS; MYCOTOXINS; ZEARALENONE;

ANIMALIA;

EID: 52949100974     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.07.011     Document Type: Article

References (43)

1. Artursson P., and Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175 (1991) 880-885
2. Avantaggiato G., Havenaar R., and Visconti A. Assessing the zearalenone-binding activity of adsorbent materials during passage through a dynamic in vitro gastrointestinal model. Food Chem. Toxicol. 41 (2003) 1283-1290
3. Biehl M.L., Prelusky D.B., Koritz G.D., Hartin K.E., Buck W.B., and Trenholm H.L. Biliairy excretion and enterohepatic cycling of zearalenone in immature pigs. Toxicol. Appl. Pharmacol. 121 (1993) 152-159
4. Boulenc X., Bourrie M., Fabre I., Roque C., Joyeux H., Berger Y., and Fabre G. Regulation of cytochrome P4501A1 expression in a human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 263 (1992) 1471-1478
5. Bony S., Carcelen M., Olivier L., and Devaux A. Genotoxicity assessment of deoxynivalenol in the Caco-2 cell line model using the Comet assay. Toxicol. Lett. 166 (2006) 67-76
6. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7 (1976) 248-254
7. Buesen R., Mock M., Seidel A., Jacob J., and Lampen A. Interaction between metabolism and transport of benzo [a]pyrene and its metabolites in enterocytes. Toxicol. Appl. Pharmacol. 183 (2002) 167-178
8. Cavret S., Videmann B., Mazallon M., and Lecoeur S. Diazinon cytotoxicity and transfer in Caco-2 cells: effect of long-term exposure to the pesticide. Environ. Toxicol. Pharm. 20 (2005) 375-380
9. Celius T., Haugen T.B., Grotmol T., and Walther B.T. A sensitive zonagenetic assay for rapid in vitro assessment of oestrogenic potency of xenobiotics and mycotoxins. Environ. Health Perspect 107 (1999) 63-68
10. Degtiar W.G., and Kushlinsky N.E. 3α-Hydroxysteroid dehydrogenase in animal and human tissues. Biochemistry (Moscow) 66 (2001) 256-266
11. Finel M., Li X., Gardner-Stephen D., Bratton S., Mackenzie P.I., and Radominska-Pandya A. Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity. J. Pharmacol. Exp. Ther. 315 (2005) 1143-1149
12. Gingras S., and Simard J. Induction of 3β-hydroysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines. Endocrinology 140 (1999) 4573-4584
13. Hidalgo I.J., Raub T.J., and Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 (1989) 736-749
14. Hirohashi T., Suzuki H., Chu X.Y., Tamai I., Tsuji A., and Sugiyama Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 292 (2000) 265-270
15. Hunter J., Jepson M.A., Tsuruo T., Simmons N.L., and Hirst B.H. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. J. Biol. Chem. 268 (1993) 14991-14997
16. Kuiper-Goodman T., Scott P.M., and Watanabe H. Risk assessment of the mycotoxin zearalenone. Regul. Toxicol. Pharmacol. 7 (1987) 253-306
17. Lampen A., Bader A., Bestmann T., Witte M., Winkler L., and Borlak J.T. Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. Xenobiotica 28 (1998) 429-441
18. Maier-Salamon A., Hagenauer B., Wirth M., Gabor F., Szekeres T., and Jäger W. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm. Res. 23 (2006) 2107-2115
19. Malekinejad H., Maas-Bakker R., and Fink-Gremmels J. Bioactivation of zearalenone by porcine hepatic biotransformation. Vet. Res. 36 (2005) 799-810
20. Malekinejad H., Maas-Bakker R., and Fink-Gremmels J. Species differences in the hepatic biotransformation of zearalenone. Vet. J. 172 (2006) 96-102
21. Malekinejad H., Van Tol H.T.A., Colenbrander B., and Fink-Gremmels J. Expression of 3α- and 3β-hydroxysteroid dehydrogenase mRNA in COCs and granulose cells determines zearalenone biotransformation. Toxicol. In Vitro 20 (2006) 458-463
22. Meunier V., Bourrie M., Berger Y., and Fabre G. The human intestinal epithelial cell line Caco-2: pharmacological and pharmacokinetic applications. Cell Biol. Toxicol. 11 (1995) 187-194
23. Miksits M., Maier-Salamon A., Aust S., Thalhammer T., Reznicek G., Kunert O., Haslinger E., Szekeres T., and Jaeger W. Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica 35 (2005) 1101-1119
24. Minervini F., Giannocarro A., Cavallini A., and Visconti A. Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the oestrogenic parameters. Toxicol. Lett. 159 (2005) 272-283
25. Mirocha C.J., Pathre S.V., and Robison T.S. Comparative metabolism of zearalenone and transmission into bovine milk. Fd. Cosmet. Toxicol. 19 (1981) 25-30
26. Naganuma M., Saruwatari A., Okamura S., and Tamura H. Tumeric and curcumin modulate the conjugation of 1-naphtol in Caco-2 cells. Biol. Pharm. Bull. 29 (2006) 1476-1479
27. Olsen M., Pettersson H., and Kiessling K.H. Reduction of zearalenone to zearalenol in female rat liver by 3α-hydroxysteroid dehydrogenase. Acta Pharmacol. Toxicol. (Copenhagen) 48 (1981) 157-161
28. Olsen M., Pettersson H., Sandholm K., Visconti A., and Kiessling K.H. Metabolism of zearalenone by sow intestinal mucosa in vitro. Food Chem. Toxicol. 25 (1987) 681-683
29. Payne A.H., Abbaszade I.G., Clarke T.R., Bain P.A., and Park C.H.J. The multiple murine 3β-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression. Steroids 62 (1997) 169-175
30. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocrinol. Rev. 18 (1997) 281-305
31. Penning T.M., Burczynsky M.E., Jez J.M., Hung C.F., Lin H.K., Ma H., Moore M., Palackal N., and Ratnam K. Human 3α-hydroxysteroid dehydrogenase isoforms (AKRC1-AKRC14) of the aldo-keto reductase supefamily: functional plasticity and tissue distribution reveals roles in the activation and formation of male and female hormones. Biochem. J. 351 (2000) 67-77
32. Pezzi V., Mathis J.M., Rainey W.E., and Carr B.R. Profiling transcript levels for steroidogenic enzymes in fetal tissues. J. Steroid Biochem. Mol. Biol. 87 (2003) 181-189
33. Pinto M., Robine-Leon S., Appay M.D., Kedinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., and Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47 (1983) 323-330
34. Pirog E.C., and Collins D.C. 3α-Hydroxysteroid dehydrogenase activity in rat liver and skin. Steroids 59 (1994) 259-264
35. Ramos A.J., Hernàndez E., Plà-Delfina J.M., and Merino M. Intestinal absorption of zearalenone and in vitro study of non-nutritive sorbent materials. Int. J. Pharm. 128 (1996) 129-137
36. Rutten A.A., Falke H.E., Catsburg J.F., Topp R., Blaauboer B.J., van Holsteijn I., Doorn L., and van Leeuwen F.X. Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Reinvestigation of assay conditions. Arch. Toxicol. 61 (1987) 27-33
37. Sabolovic N., Magdalou J., Netter P., and Abid A. Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells. Identification of the UDP-glucuronosyltransferases UGT1A6, 1A3, and 2B7. Life Sci. 67 (2000) 185-196
38. Shier W.T., Shier A.C., Xie W., and Mirocha C.J. Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon 39 (2001) 1435-1438
39. Taipalensuu J., Törnblom H., Lindberg G., Einarsson C., Sjökvist F., Melhus H., Garberg P., Sjöström B., Lundgren B., and Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 299 (2001) 164-170
40. Tep J., Videmann B., Mazallon M., Balleydier S., Cavret S., and Lecoeur S. Transepithelial transport of fusariotoxin nivalenol: mediation of secretion by ABC transporters. Toxicol. Lett. 170 (2007) 248-258
41. Trenholm H.L., Warner R.M., and Fitzpatrick D.W. Rapid, sensitive liquid chromatographic method for determination of zearalenone and alpha- and beta-zearalenol in wheat. J. Assoc. Off. Anal. Chem. 67 (1984) 968-972
42. Videmann B., Tep J., Cavret S., and Lecoeur S. Epithelial transport of deoxynivalenol: involvement of human p-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food Chem. Toxicol. 45 (2007) 1938-1947
43. Zinedine A., Soriano J.M., Molto J.C., and Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 45 (2007) 1-18